| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sullivan Adam Taylor | Chief Executive Officer, Director | C/O CORE SCIENTIFIC, INC., 838 WALKER ROAD, SUITE 21-2105, DOVER | /s/ Todd DuChene, as Attorney-in-Fact | 05 Jan 2026 | 0001980208 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CORZ | Common Stock | Award | $0 | +159,308 | +3.7% | $0.000000 | 4,523,244 | 31 Dec 2025 | Direct | F1, F2 |
| transaction | CORZ | Common Stock | Tax liability | $1,772,503 | -117,540 | -2.6% | $15.08 | 4,405,704 | 31 Dec 2025 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents the acquisition of additional performance-based restricted stock units in connection with the 300% vesting of the second installment of the Reporting Person's performance-based restricted stock units granted on June 14, 2024, and previously reported at 100% vesting in the Form 4 filed by the Reporting Person on June 17, 2024. |
| F2 | Reported amount reflects the acquisition of 336 shares of Common Stock that the Reporting Person received on December 24, 2025 for no consideration in connection with an in-kind distribution by XMS XPDI Sponsor Holdings LLC, which was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act. |
| F3 | Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. |